Compounds > n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide
Page last updated: 2024-09-03

n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide and Substance Withdrawal Syndrome

n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide has been researched along with Substance Withdrawal Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Misawa, M; Suzuki, T; Tsuda, M1

Other Studies

1 other study(ies) available for n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide and Substance Withdrawal Syndrome

ArticleYear
Subsensitivity to mitochondrial diazepam binding inhibitor receptor agonist FGIN-1-27-induced antiseizure effect in diazepam-withdrawn mice.
    Life sciences, 1998, Volume: 62, Issue:14

    Topics: Animals; Anticonvulsants; Diazepam; Indoleacetic Acids; Injections, Intraventricular; Male; Mice; Mitochondria; Receptors, Cytoplasmic and Nuclear; Substance Withdrawal Syndrome

1998